Primer Presentations
| 3:00 pm - 3:05 pm | Welcome and Introduction |
| 3:05 pm - 3:40 pm | Cancer VaccinesCarmen Scheibenbogen, MD - Institut für Med. Immunologie, Charité, Berlin |
| 3:40 pm - 4:15 pm | T Cell TherapyPatrick Hwu, MD - MD Anderson Cancer Center |
| 4:15 pm - 4:50 pm | Host-Tumor InterationsFrancesco Marincola, MD - National Institutes of Health |
| 4:50 pm - 5:25 pm | Vaccine Adjuvants, Antigen Processing and Immune Tolerance Kenneth Rock, MD - University of Massachusetts |
| 5:45 pm - 6:20 pm | In Vivo Immunity: Integrating Innate and Adaptive Immunity - The Role of Danger Polly Matzinger, PhD - National Institutes of Allergy and Infectious Diseases |
| 6:20 pm - 6:55 pm | Normalization of the Tumor Microenvironment by Antiangiogenic Therapy Rakesh K. Jain, PhD - Harvard Medical School
|
| 6:55 pm - 7:30 pm | Angiogenesis as an "Organizing Principle" in Biology Judah Folkman, MD - Children's Hospital Boston |
| 7:30 pm - 8:05 pm | Antibody Therapy, Biology, Immunocytokines and Hematologic MalignancyPaul M. Sondel, MD, PhD - University of Wisconsin
|
| 8:15 pm - 8:50 pm | Antibody Therapy of Solid Tumors Louis M. Weiner, MD - Fox Chase Cancer Center |
| 8:50 pm - 9:25 pm | Immunotoxin Therapy of Cancer: Successes and ChallengesIra H. Pastan, MD - National Institutes of Health |
| 9:25 pm - 10:00 pm | Cytokines in Malignancy Kim A. Margolin, MD - City of Hope Cancer Center |
All presentations are licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
